FAQ: Nutriband Inc. CEO Named EY Entrepreneur of the Year 2025 Finalist

What is Nutriband Inc.?

Nutriband Inc. is a life sciences company focused on the development of transdermal pharmaceutical products, notably its AVERSA™ abuse-deterrent technology designed to prevent the misuse and abuse of drugs with abuse potential.

Why was Gareth Sheridan named a finalist for the EY Entrepreneur of the Year 2025?

Gareth Sheridan was recognized for his leadership in transforming Nutriband from an early-stage startup into a U.S.-listed company with significant contributions to transdermal drug delivery and abuse-deterrent technologies.

What is AVERSA technology?

AVERSA technology is Nutriband’s abuse-deterrent technology that can be incorporated into any transdermal patch to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential.

How many entrepreneurs were recognized in the 2025 EY Entrepreneur of the Year Awards?

27 Irish entrepreneurs from across 24 companies generating more than €1 billion in annual revenue were recognized as finalists in the 2025 EY Entrepreneur of the Year Awards.

What will the finalists of the EY Entrepreneur of the Year Awards participate in?

Finalists will participate in a CEO retreat in Japan and compete for the overall Entrepreneur of the Year title, which will be awarded at a gala event in November.

Where can I find more information about Nutriband Inc.?

More information about Nutriband Inc. can be found on their website at www.Nutriband.com.

Where can I view the full article about Gareth Sheridan’s recognition?

The full article can be viewed at https://ibn.fm/FNBFI.

What is the significance of Nutriband’s lead product, AVERSA?

AVERSA addresses a critical gap in pain management by preventing the misuse and abuse of opioid patches, showcasing Nutriband’s commitment to innovative solutions in the pharmaceutical industry.